SO

Sophia Genetics SANASDAQ SOPH Stock Report

Last reporting period 30 Sep, 2024

Updated 12 Nov, 2024

Last price

Market cap $B

0.245

Micro

Exchange

XNAS - Nasdaq

SOPH Stock Analysis

SO

Uncovered

Sophia Genetics SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-25/100

Low score

Market cap $B

0.245

Dividend yield

Shares outstanding

62.068 B

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

View Section: Eyestock Rating